Read + Share
Nystrom T. Key results from observational studies and real-world evidence of sodium-glucose
cotransporter-2 inhibitor effectiveness and safety in reducing cardio-renal risk. Diabetes Obes Metab 2024;26 Suppl 5:35-57.
PMID: 38859661
|
 |
|
Nystrom T. Key results from observational studies and real-world evidence of sodium-glucose
cotransporter-2 inhibitor effectiveness and safety in reducing cardio-renal risk. Diabetes Obes Metab 2024;26 Suppl 5:35-57.
PMID: 38859661
|
|
|
|